XGBoost model predicted PMOS status from detailed body-composition measures with AUC 0.701 in testing, with SHAP highlighting regional fat masses as top predictors.
Using GBD 2021 data, Mendelian randomization, and a clinical cohort, the study quantified global PMOS burden and tested adiposity as a causal determinant, then built machine-learning models from body-composition measures to predict PMOS, with XGBoost reaching AUC 0.701 and SHAP highlighting left-leg and trunk fat mass.
- Impact 30%
- 49
- Evidence 25%
- 95
- Scale 20%
- 85
- Confidence 15%
- 87
- Recency 10%
- 94
Updated Sep 9, 2026 · TRV-2026-1034
ace